Riverview Capital Advisers, LLC Pfizer Inc Transaction History

Riverview Capital Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $6,418 - $7,502	-200 Reduced 0.74%	26,708 $885,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $39,190 - $45,342	1,085 Added 4.2%	26,908 $986,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $1,693 - $2,205	43 Added 0.17%	25,823 $1.05 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $1,377 - $1,798	33 Added 0.13%	25,780 $1.32 Million
Q3 2022 Feb 07, 2023	BUY	$43.76 - $53.42 $1,575 - $1,923	36 Added 0.14%	25,747 $1.13 Billion
Q2 2022 Feb 07, 2023	BUY	$46.53 - $55.17 $11,074 - $13,130	238 Added 0.93%	25,711 $1.35 Billion
Q1 2022 Feb 07, 2023	BUY	$45.75 - $56.69 $43,050 - $53,345	941 Added 3.84%	25,473 $1.32 Billion
Q4 2021 Feb 07, 2023	BUY	$41.32 - $61.25 $1.01 Million - $1.5 Million	24,532 New	24,532 $1.45 Billion

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Riverview Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Riverview Capital Advisers, LLC with notifications on news.